RxMP Therapeutics featured on BioPub

Written By Shelley Chen

RxMP Therapeutics featured again on BioPub. Dr. Rif Pamukcu CEO and Dr. Mike Davis, former Director of the U.S. Combat Casualty Care Research Program, give shareholders an update on the current raise and outlook for 2024.

Shelley Chen
Previous

RxMP Therapeutics Provides Documents for Latest Raise.
Next

RxMP Therapeutics featured on BioPub